Download PDF
J Pediatr Genet 2023; 12(02): 113-122
DOI: 10.1055/s-0043-1763258
Review Article

Congenital Heart Defects and 22q11.2 Deletion Syndrome: A 20-Year Update and New Insights to Aid Clinical Diagnosis

Bruna Lixinski Diniz 
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
,
Desirée Deconte 
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
,
Kerolainy Alves Gadelha 
2   Underdegree Program in Biomedicine, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
,
Andressa Barreto Glaeser 
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
,
Bruna Baierle Guaraná
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
3   Department of Internal Medicine, Clinical Genetics Service, Federal University of Health Sciences of Porto Alegre (UFCSPA) and Irmandade da Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, RS, Brazil
,
Andreza Ávila de Moura
2   Underdegree Program in Biomedicine, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
,
Rafael Fabiano Machado Rosa
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
3   Department of Internal Medicine, Clinical Genetics Service, Federal University of Health Sciences of Porto Alegre (UFCSPA) and Irmandade da Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, RS, Brazil
,
Paulo Ricardo Gazzola Zen 
1   Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
3   Department of Internal Medicine, Clinical Genetics Service, Federal University of Health Sciences of Porto Alegre (UFCSPA) and Irmandade da Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, RS, Brazil
› Author Affiliations Funding This work was funding by Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS,17/2551-0001063-9), Programa de Extensão Universitária do Ministério da Educação e Cultura (PROEXT), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001, and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (302931/2019-8).
› Further Information
    Permissions and Reprints

Abstract

Congenital heart defects (CHDs) are one of the most prevalent clinical features described in individuals diagnosed with 22q11.2 deletion syndrome (22q11.2DS). Therefore, cardiac malformations may be the main finding to refer for syndrome investigation, especially in individuals with a mild phenotype. Nowadays, different cytogenetic methodologies have emerged and are used routinely in research laboratories. Hence, choosing an efficient technology and providing an accurate interpretation of clinical findings is crucial for 22q11.2DS patient's diagnosis.

This systematic review provides an update of the last 20 years of research on 22q11.2DS patients with CHD and the investigation process behind each diagnosis. A search was performed in PubMed, Embase, and LILACS using all entry terms to DiGeorge syndrome, CHDs, and cytogenetic analysis. After screening, 60 papers were eligible for review. We present a new insight of ventricular septal defect as a possible pivotal cardiac finding in individuals with 22q11.2DS. Also, we describe molecular technologies and cardiac evaluation as valuable tools in order to guide researchers in future investigations.

Keywords

22q11.2 deletion syndrome - congenital heart defects - DiGeorge syndrome - ventricular heart septal defects

Ethical Approval

This study did not require ethical approval.


Supplementary Material



Publication History

Received: 30 April 2021

Accepted: 16 January 2023

Article published online:
17 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008; 14 (01) 3-10
    CrossrefPubMedGoogle Scholar
  • 2 Morrow BE, McDonald-McGinn DM, Emanuel BS, Vermeesch JR, Scambler PJ. Molecular genetics of 22q11.2 deletion syndrome. Am J Med Genet A 2018; 176 (10) 2070-2081
    CrossrefPubMedGoogle Scholar
  • 3 Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet 2020; 184 (01) 64-72
    CrossrefPubMedGoogle Scholar
  • 4 McDonald-McGinn DM, Sullivan KE, Marino B. et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015; 1: 15071
    CrossrefPubMedGoogle Scholar
  • 5 Swillen A, McDonald-McGinn D. Developmental trajectories in 22q11.2 deletion. Am J Med Genet C Semin Med Genet 2015; 169 (02) 172-181
    CrossrefPubMedGoogle Scholar
  • 6 Mastroiacovo P, Rossi P, Cancrini C. et al. Chromosome 22q.11 deletion: recommendations for diagnosis and treatment. Italian Primary Immunodeficiencies Strategic Scientific Committee; 2005. Accessed November 25, 2020, at: http://www.aieop.org/stdoc/prot/rec_del22_en_06.pdf
    PubMedGoogle Scholar
  • 7 Mutlu ET, Aykan HH, Karagöz T. Analysis of gene copy number variations in patients with congenital heart disease using multiplex ligation-dependent probe amplification. Anatol J Cardiol 2018; 20 (01) 9-15
    PubMedGoogle Scholar
  • 8 Zhang J, Ma D, Wang Y. et al. Analysis of chromosome 22q11 copy number variations by multiplex ligation-dependent probe amplification for prenatal diagnosis of congenital heart defect. Mol Cytogenet 2015; 8: 100
    CrossrefPubMedGoogle Scholar
  • 9 Peng R, Xie HN, Zheng J, Zhou Y, Lin MF. Fetal right aortic arch: associated anomalies, genetic anomalies with chromosomal microarray analysis, and postnatal outcome. Prenat Diagn 2017; 37 (04) 329-335 [published correction appears in Prenat Diagn. 2018 Mar;38(4):298]
    CrossrefPubMedGoogle Scholar
  • 10 Chen CP, Huang JP, Chen YY. et al. Chromosome 22q11.2 deletion syndrome: prenatal diagnosis, array comparative genomic hybridization characterization using uncultured amniocytes and literature review. Gene 2013; 527 (01) 405-409
    CrossrefPubMedGoogle Scholar
  • 11 Fu F, Deng Q, Lei TY. et al. Clinical application of SNP array analysis in fetuses with ventricular septal defects and normal karyotypes. Arch Gynecol Obstet 2017; 296 (05) 929-940
    CrossrefPubMedGoogle Scholar
  • 12 Mcconnell ME. Tetralogy of Fallot. In: Garfunkel LC, Kaczorowski JM, Christy C. eds. Pediatric Clinical Advisor. 2nd ed. Missouri, United States: Mosby; 2007. :557
    Google Scholar
  • 13 Snider P, Conway JS. Probing human cardiovascular congenital disease using transgenic mouse models. In: Chang KT, Min K-T. eds. Progress in Molecular Biology and Translational Science. Massachusetts, United States: Academic Press; 2011: 83-110
    Google Scholar
  • 14 Jaouadi A, Tabebi M, Abdelhedi F. et al. A novel TBX1 missense mutation in patients with syndromic congenital heart defects. Biochem Biophys Res Commun 2018; 499 (03) 563-569
    CrossrefPubMedGoogle Scholar
  • 15 Chen M, Yang YS, Shih JC. et al. Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization. Ultrasound Obstet Gynecol 2014; 43 (04) 396-403
    CrossrefPubMedGoogle Scholar
  • 16 Rauch A, Hofbeck M, Cesnjevar R. et al. Search for somatic 22q11.2 deletions in patients with conotruncal heart defects. Am J Med Genet A 2004; 124A (02) 165-169
    CrossrefPubMedGoogle Scholar
  • 17 Iascone MR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S. Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet 2002; 108 (04) 319-321
    CrossrefPubMedGoogle Scholar
  • 18 Vittorini S, Sacchelli M, Iascone MR. et al. Molecular characterization of chromosome 22 deletions by short tandem repeat polymorphism (STRP) in patients with conotruncal heart defects. Clin Chem Lab Med 2001; 39 (12) 1249-1258
    CrossrefPubMedGoogle Scholar
  • 19 Pires R, Pires LM, Vaz SO. et al. Screening of copy number variants in the 22q11.2 region of congenital heart disease patients from the São Miguel Island, Azores, revealed the second patient with a triplication. BMC Genet 2014; 15: 115
    CrossrefPubMedGoogle Scholar
  • 20 Kuo YL, Chen CP, Wang LK. et al. Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects. Taiwan J Obstet Gynecol 2014; 53 (02) 248-251
    CrossrefPubMedGoogle Scholar
  • 21 Gao W, Higaki T, Eguchi-Ishimae M. et al. DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects. Hum Genome Var 2015; 2: 15004
    CrossrefPubMedGoogle Scholar
  • 22 Beaujard MP, Chantot S, Dubois M. et al. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays. Eur J Med Genet 2009; 52 (05) 321-327
    CrossrefPubMedGoogle Scholar
  • 23 Garavelli L, Rosato S, Wischmeijer A. et al. 22q11.2 distal deletion syndrome: description of a new case with truncus arteriosus type 2 and review. Mol Syndromol 2011; 2 (01) 35-44
    CrossrefPubMedGoogle Scholar
  • 24 Athanasiadis DI, Mylonas KS, Kasparian K. et al. Surgical outcomes in syndromic tetralogy of Fallot: a systematic review and evidence quality assessment. Pediatr Cardiol 2019; 40 (06) 1105-1112
    CrossrefPubMedGoogle Scholar
  • 25 Penny DJ, Vick III GW. Ventricular septal defect. Lancet 2011; 377 (9771): 1103-1112
    CrossrefPubMedGoogle Scholar
  • 26 Ryan AK, Goodship JA, Wilson DI. et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34 (10) 798-804
    CrossrefPubMedGoogle Scholar
  • 27 Botto LD, May K, Fernhoff PM. et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112 (1 Pt 1): 101-107
    CrossrefPubMedGoogle Scholar
  • 28 Kaul S. The interventricular septum in health and disease. Am Heart J 1986; 112 (03) 568-581
    CrossrefPubMedGoogle Scholar
  • 29 Liu Y, Chen S, Zühlke L. et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48 (02) 455-463
    CrossrefPubMedGoogle Scholar
  • 30 Downing TE, Kim YY. Tetralogy of Fallot: general principles of management. Cardiol Clin 2015; 33 (04) 531-541 , vii–viii
    CrossrefPubMedGoogle Scholar
  • 31 Sandoval JP, Chaturvedi RR, Benson L. et al. Right ventricular outflow tract stenting in tetralogy of Fallot infants with risk factors for early primary repair. Circ Cardiovasc Interv 2016; 9 (12) e003979
    CrossrefPubMedGoogle Scholar
  • 32 Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30 (12) e57
    CrossrefPubMedGoogle Scholar
  • 33 Edelmann L, Hirschhorn K. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci 2009; 1151: 157-166
    CrossrefPubMedGoogle Scholar
  • 34 Di Franco A, Ohmes LB, Gaudino M. et al. Serendipity and innovation: history and evolution of transthoracic echocardiography. J Thorac Dis 2017; 9 (Suppl. 04) S257-S263
    CrossrefPubMedGoogle Scholar
  • 35 McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90 (01) 1-18
    CrossrefPubMedGoogle Scholar
  • 36 Carlson C, Sirotkin H, Pandita R. et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 1997; 61 (03) 620-629
    CrossrefPubMedGoogle Scholar
  • 37 Sebat J, Lakshmi B, Troge J. et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305 (5683): 525-528
    CrossrefPubMedGoogle Scholar
  • 38 Thienpont B, Mertens L, de Ravel T. et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007; 28 (22) 2778-2784
    CrossrefPubMedGoogle Scholar
  • 39 Southard AE, Edelmann LJ, Gelb BD. Role of copy number variants in structural birth defects. Pediatrics 2012; 129 (04) 755-763
    CrossrefPubMedGoogle Scholar
  • 40 Choi BG, Hwang SK, Kwon JE, Kim YH. Array comparative genomic hybridization as the first-line investigation for neonates with congenital heart disease: experience in a single tertiary center. Korean Circ J 2018; 48 (03) 209-216
    CrossrefPubMedGoogle Scholar
  • 41 Nagy O, Szakszon K, Biró BO. et al. Copy number variants detection by microarray and multiplex ligation-dependent probe amplification in congenital heart diseases. J Biotechnol 2019; 299: 86-95
    CrossrefPubMedGoogle Scholar
  • 42 Stuppia L, Antonucci I, Palka G, Gatta V. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci 2012; 13 (03) 3245-3276
    CrossrefPubMedGoogle Scholar
  • 43 Monteiro RAC, de Freitas ML, Vianna GS. et al. Major contribution of genomic copy number variation in syndromic congenital heart disease: the use of MLPA as the first genetic test. Mol Syndromol 2017; 8 (05) 227-235
    CrossrefPubMedGoogle Scholar
  • 44 Sørensen KM, El-Segaier M, Fernlund E. et al. Screening of congenital heart disease patients using multiplex ligation-dependent probe amplification: early diagnosis of syndromic patients. Am J Med Genet A 2012; 158A (04) 720-725
    CrossrefPubMedGoogle Scholar
  • 45 Fernández L, Nevado J, Santos F. et al. A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med Genet 2009; 10: 48
    CrossrefPubMedGoogle Scholar
  • 46 Gunjan A, Paik J, Verreault A. Regulation of histone synthesis and nucleosome assembly. Biochimie 2005; 87 (07) 625-635
    CrossrefPubMedGoogle Scholar
  • 47 Arsham MS, Barch MJ, Lawce HJ. The AGT Cytogenetics Laboratory Manual. 4 ed. John Wiley & Sons; 2017
    CrossrefGoogle Scholar
  • 48 Pierpont ME, Basson CT, Benson Jr DW. et al; American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115 (23) 3015-3038
    CrossrefPubMedGoogle Scholar